MX2015009429A - Tratamiento de rinitis alergica utilizando una combinacion de mometasona y olopatadina. - Google Patents
Tratamiento de rinitis alergica utilizando una combinacion de mometasona y olopatadina.Info
- Publication number
- MX2015009429A MX2015009429A MX2015009429A MX2015009429A MX2015009429A MX 2015009429 A MX2015009429 A MX 2015009429A MX 2015009429 A MX2015009429 A MX 2015009429A MX 2015009429 A MX2015009429 A MX 2015009429A MX 2015009429 A MX2015009429 A MX 2015009429A
- Authority
- MX
- Mexico
- Prior art keywords
- olopatadine
- mometasone
- combination
- treatment
- allergy rhinitis
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Otolaryngology (AREA)
- Pulmonology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Dermatology (AREA)
- Ophthalmology & Optometry (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN3174MU2013 | 2013-10-04 | ||
| PCT/IB2014/065035 WO2015049665A1 (en) | 2013-10-04 | 2014-10-03 | Treatment of allergic rhinitis using a combination of mometasone and olopatadine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2015009429A true MX2015009429A (es) | 2015-10-09 |
Family
ID=51982657
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2015009429A MX2015009429A (es) | 2013-10-04 | 2014-10-03 | Tratamiento de rinitis alergica utilizando una combinacion de mometasona y olopatadina. |
| MX2020003035A MX2020003035A (es) | 2013-10-04 | 2015-07-22 | Tratamiento de rinitis alergica utilizando una combinacion de mometasona y olopatadina. |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2020003035A MX2020003035A (es) | 2013-10-04 | 2015-07-22 | Tratamiento de rinitis alergica utilizando una combinacion de mometasona y olopatadina. |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US10646500B2 (enExample) |
| EP (2) | EP2922553B1 (enExample) |
| JP (3) | JP6419195B2 (enExample) |
| CN (2) | CN112773808A (enExample) |
| HK (1) | HK1215674A1 (enExample) |
| MX (2) | MX2015009429A (enExample) |
| MY (1) | MY176808A (enExample) |
| PH (1) | PH12015502302A1 (enExample) |
| RU (1) | RU2686670C2 (enExample) |
| UA (1) | UA120587C2 (enExample) |
| WO (1) | WO2015049665A1 (enExample) |
| ZA (1) | ZA201504740B (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9370483B2 (en) | 2013-09-13 | 2016-06-21 | Glenmark Specialty S.A. | Stable fixed dose pharmaceutical composition comprising mometasone and olopatadine |
| US10646500B2 (en) * | 2013-10-04 | 2020-05-12 | Glenmark Specialty S.A. | Treatment of allergic rhinitis using a combination of mometasone and olopatadine |
| US9937189B2 (en) | 2013-09-13 | 2018-04-10 | Glenmark Specialty S.A. | Stable fixed dose pharmaceutical composition comprising mometasone and olopatadine |
| US10548907B2 (en) | 2013-10-04 | 2020-02-04 | Glenmark Specialty S.A. | Treatment of allergic rhinitis using a combination of mometasone and olopatadine |
| US10016443B2 (en) | 2013-10-04 | 2018-07-10 | Glenmark Specialty S.A. | Treatment of allergic rhinitis using a combination of mometasone and olopatadine |
| US10653661B2 (en) | 2013-10-04 | 2020-05-19 | Glenmark Specialty S.A. | Treatment of allergic rhinitis using a combination of mometasone and olopatadine |
| US10758550B2 (en) | 2013-10-04 | 2020-09-01 | Glenmark Specialty S.A. | Treatment of allergic rhinitis using a combination of mometasone and olopatadine |
| US11679210B2 (en) | 2014-10-03 | 2023-06-20 | Glenmark Specialty S.A. | Dispensing device and pharmaceutical composition for the treatment of rhinitis |
| AU2018260934B2 (en) * | 2017-06-28 | 2023-10-19 | Glenmark Specialty S.A. | Dispensing device and pharmaceutical compositions for the treatment of rhinitis |
| HRP20250411T1 (hr) * | 2018-02-23 | 2025-07-18 | Glenmark Specialty S.A. | Liječenje alergijskog rinitisa kod pedijatrijskih subjekata kombinacijom mometazona i olopatadina |
| US12303635B2 (en) | 2018-04-16 | 2025-05-20 | Glenmark Specialty S.A. | Dispensing device and pharmaceutical composition for the treatment of rhinitis |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4923892A (en) | 1985-08-17 | 1990-05-08 | Burroughs Wellcome Co. | Tricyclic aromatic compounds |
| GB8520662D0 (en) | 1985-08-17 | 1985-09-25 | Wellcome Found | Tricyclic aromatic compounds |
| US6127353A (en) | 1991-09-06 | 2000-10-03 | Schering Corporation | Mometasone furoate monohydrate, process for making same and pharmaceutical compositions |
| US5837699A (en) * | 1994-01-27 | 1998-11-17 | Schering Corporation | Use of mometasone furoate for treating upper airway passage diseases |
| PE44995A1 (es) | 1994-01-27 | 1995-12-18 | Schering Corp | Furoato de mometasona para el tratamiento de las enfermedades pulmonares y de las vias respiratorias |
| ES2284531T3 (es) | 1999-10-08 | 2007-11-16 | Schering Corporation | Tratamiento nasal topico usando desloratadina y furoato de mometasona. |
| US7977376B2 (en) | 2001-06-27 | 2011-07-12 | Novartis Ag | Olopatadine formulations for topical nasal administration |
| BR0316203A (pt) * | 2002-11-12 | 2005-10-04 | Alcon Inc | Uso de um agente antialérgico e um esteróide para tratar rinite alérgica |
| US8912174B2 (en) | 2003-04-16 | 2014-12-16 | Mylan Pharmaceuticals Inc. | Formulations and methods for treating rhinosinusitis |
| DK1814538T3 (da) | 2004-11-24 | 2009-11-02 | Alcon Inc | Fremgangsmåde til administration af næsespray |
| BRPI0615032A2 (pt) * | 2005-09-01 | 2011-04-26 | Biolipox Ab | composição farmacêutica, processo para a preparação da mesma, e, uso de uma composição |
| US20120121653A1 (en) | 2005-12-02 | 2012-05-17 | Elan Pharma International Limited | Novel mometasone compositions and methods of making and using the same |
| JP5185109B2 (ja) | 2006-04-21 | 2013-04-17 | 東興薬品工業株式会社 | スプレー用ゲルタイプ皮膚・粘膜付着型製剤およびそれを用いた投与システム |
| CN106038481A (zh) * | 2007-06-28 | 2016-10-26 | 锡德克斯药物公司 | 皮质类固醇水溶液的鼻部和眼部给药 |
| RU2011101151A (ru) | 2008-07-15 | 2012-07-20 | Шеринг Корпорейшн (US) | Интраназальные композиции, содержащие деконгестант и кортикостероид |
| WO2010025236A1 (en) | 2008-08-27 | 2010-03-04 | Alexander Goldin | Composition and method for treating colds |
| AU2010273347B2 (en) | 2009-07-17 | 2015-04-30 | Alcon Research, Ltd. | Olopatadine nasal spray regimen for children |
| CN102078326A (zh) * | 2009-11-26 | 2011-06-01 | 天津金耀集团有限公司 | 含有聚维酮碘与糠酸莫米松的局部使用组合物 |
| CN102078285A (zh) * | 2009-11-26 | 2011-06-01 | 天津金耀集团有限公司 | 含有皮质激素和h1受体拮抗剂的鼻用原位凝胶 |
| WO2011141929A2 (en) | 2010-05-11 | 2011-11-17 | Cadila Healthcare Limited | Aqueous pharmaceutical compositions of fluticasone and olopatadine |
| WO2012094283A2 (en) | 2011-01-04 | 2012-07-12 | Ista Pharmaceuticals, Inc. | Bepotastine compositions |
| MX2015005081A (es) | 2012-10-25 | 2015-07-17 | Novozymes As | Metodo mejorado para el lavado manual de la vajilla. |
| KR20140081925A (ko) * | 2012-12-12 | 2014-07-02 | 한미약품 주식회사 | 코르티코스테로이드, 항히스타민제 및 스테비아를 포함하는 고미 차폐된 약학 제제 |
| MY191380A (en) | 2013-09-13 | 2022-06-21 | Glenmark Specialty Sa | Stabilized fixed dose drug composition having mometasone and olopatadine |
| US10646500B2 (en) * | 2013-10-04 | 2020-05-12 | Glenmark Specialty S.A. | Treatment of allergic rhinitis using a combination of mometasone and olopatadine |
| US9370483B2 (en) | 2013-09-13 | 2016-06-21 | Glenmark Specialty S.A. | Stable fixed dose pharmaceutical composition comprising mometasone and olopatadine |
-
2014
- 2014-10-03 US US14/506,122 patent/US10646500B2/en active Active
- 2014-10-03 CN CN202110299649.8A patent/CN112773808A/zh active Pending
- 2014-10-03 EP EP14802944.0A patent/EP2922553B1/en active Active
- 2014-10-03 RU RU2015128496A patent/RU2686670C2/ru active
- 2014-10-03 JP JP2016546191A patent/JP6419195B2/ja active Active
- 2014-10-03 WO PCT/IB2014/065035 patent/WO2015049665A1/en not_active Ceased
- 2014-10-03 EP EP23198254.7A patent/EP4272839A3/en active Pending
- 2014-10-03 MY MYPI2015702416A patent/MY176808A/en unknown
- 2014-10-03 HK HK16103630.2A patent/HK1215674A1/zh unknown
- 2014-10-03 CN CN201480066538.0A patent/CN105792828A/zh active Pending
- 2014-10-03 UA UAA201507124A patent/UA120587C2/uk unknown
- 2014-10-03 MX MX2015009429A patent/MX2015009429A/es active IP Right Grant
-
2015
- 2015-07-01 ZA ZA2015/04740A patent/ZA201504740B/en unknown
- 2015-07-22 MX MX2020003035A patent/MX2020003035A/es unknown
- 2015-10-05 PH PH12015502302A patent/PH12015502302A1/en unknown
-
2018
- 2018-04-11 JP JP2018076047A patent/JP6768733B2/ja active Active
-
2020
- 2020-02-21 JP JP2020028523A patent/JP2020097624A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP2922553A1 (en) | 2015-09-30 |
| JP2018123157A (ja) | 2018-08-09 |
| MY176808A (en) | 2020-08-21 |
| WO2015049665A1 (en) | 2015-04-09 |
| US10646500B2 (en) | 2020-05-12 |
| RU2015128496A3 (enExample) | 2018-06-19 |
| RU2686670C2 (ru) | 2019-04-30 |
| EP2922553B1 (en) | 2026-05-06 |
| US20150099725A1 (en) | 2015-04-09 |
| HK1215674A1 (zh) | 2016-09-09 |
| EP4272839A3 (en) | 2024-01-03 |
| ZA201504740B (en) | 2016-10-26 |
| JP6419195B2 (ja) | 2018-11-07 |
| PH12015502302B1 (en) | 2016-02-15 |
| RU2015128496A (ru) | 2017-11-13 |
| JP6768733B2 (ja) | 2020-10-14 |
| CN105792828A (zh) | 2016-07-20 |
| PH12015502302A1 (en) | 2016-02-15 |
| RU2019104453A (ru) | 2019-03-28 |
| CN112773808A (zh) | 2021-05-11 |
| UA120587C2 (uk) | 2020-01-10 |
| JP2020097624A (ja) | 2020-06-25 |
| JP2016531949A (ja) | 2016-10-13 |
| EP4272839A2 (en) | 2023-11-08 |
| MX2020003035A (es) | 2020-07-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2020003035A (es) | Tratamiento de rinitis alergica utilizando una combinacion de mometasona y olopatadina. | |
| IL261884B (en) | Compositions of natural extracts and use thereof in methods for preventing or treating diseases | |
| IL260585B (en) | Compositions and methods for treating retinal diseases | |
| IL239923A0 (en) | Solid solution compositions and use in cardiovascular disease | |
| LT3672954T (lt) | Junginiai, jų druskos ir jų naudojimas ligoms gydyti | |
| EP4173663C0 (en) | DEVICE SUITABLE FOR USE IN THE TREATMENT OF RESPIRATORY DISEASES | |
| PL2970101T5 (pl) | Proleki fumaranów i ich zastosowanie w leczeniu różnych chorób | |
| IL238432A0 (en) | Methods and devices for the treatment of ocular diseases in human subjects | |
| SI4000608T1 (sl) | Farmacevtski sestavek, postopki za zdravljenje in njegove uporabe | |
| PL4374873T3 (pl) | Środek do stosowania w leczeniu lub zapobieganiu schorzeniom okulistycznym | |
| AR101740A1 (es) | Terapia de combinación y composiciones | |
| PT3043862T (pt) | Método para verificação e garantia de qualidade de tratamento radioterapêutico específico de paciente | |
| HUE046671T2 (hu) | Glutárimid származékokat tartalmazó gyógyászati készítmény, valamint ennek alkalmazása eozinofil betegségek kezelésében | |
| BR112015027477A8 (pt) | bolus, seus usos, e kit | |
| SI3838271T1 (sl) | Zdravljenje povišanih ravni eozinofilcev in/ali bazofilcev | |
| HRP20180337T1 (hr) | Kalcitonin mimetika za liječenje bolesti i poremećaja | |
| EP2948195A4 (en) | INCLUDED DEVICES FOR THE TREATMENT OF MEDICAL WASTE AND METHOD FOR THE USE THEREOF | |
| WO2015197193A3 (en) | New use for jnk inhibitor molecules for treatment of various diseases | |
| MX2018012285A (es) | Metodos de tratamiento para enfermedades colestasicas y fibroticas. | |
| JOP20190056B1 (ar) | مركبات للاستخدام في علاج القصور الكلوي الحاد | |
| LT2958624T (lt) | Transplantuotų pacientų transplantanto prieš šeiminiką ligos gydymas | |
| FI20115165A0 (fi) | Terapeuttisia ja diagnostisia menetelmiä | |
| HUE040027T2 (hu) | Taurourzodezoxikólsav (TUDCA) neurodegeneratív betegségek kezelésében történõ alkalmazásra | |
| SI3228313T1 (sl) | Odmerne oblike in terapevtske uporabe L-4-klorokinurenina | |
| IL243192B (en) | Therapeutic agents for use in the prophylaxis and/or treatment of hyperkinetic movement disorders |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GB | Transfer or rights |
Owner name: GLENMARK SPECIALTY S.A. |
|
| FG | Grant or registration |